The Israeli startup has developed an advanced antimicrobial platform to eliminate pathogens and will collaborate with the Gadot Group, which specializes in chemical production and logistics and is a part of the group that won the tender to privatize the port of Haifa with the Indian Adani Group.
Israeli startup Nanosono, which has developed an antimicrobial platform that eliminates disease-causing pathogens from products and surfaces, announced that it has signed a strategic agreement with the Gadot Group, which will include a $2 million investment.
Gadot Group specializes in chemical production and logistics and is a part of the group that won the tender to privatize the port of Haifa with the Indian Adani Group in a deal valued at NIS 4.1 billion (approximately $1.17 billion).
As part of the cooperation with Nanosono, Gadot will build the necessary infrastructure and production line to produce the startup’s antimicrobial technology, known as QUACTIV, that was developed in Nanosono's laboratories in Yokneam.
In addition, Gadot will invest $2 million in Nanosono, while providing the company with various logistical services to allow faster penetration to new markets.
To date, Nanosono has raised $21 million, with the U.S.-based AHG Group and Dr. Michael Mirilashvili among the investors.
https://www.nanosono.com
